GR3017407T3 - Specific binding agents. - Google Patents

Specific binding agents.

Info

Publication number
GR3017407T3
GR3017407T3 GR950402540T GR950402540T GR3017407T3 GR 3017407 T3 GR3017407 T3 GR 3017407T3 GR 950402540 T GR950402540 T GR 950402540T GR 950402540 T GR950402540 T GR 950402540T GR 3017407 T3 GR3017407 T3 GR 3017407T3
Authority
GR
Greece
Prior art keywords
human antibody
reshaped
specific binding
binding agents
plap
Prior art date
Application number
GR950402540T
Other languages
English (en)
Inventor
Martine Elisa Verhoeyen
Original Assignee
Unilever Plc
Unilever Nv
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from GB898926045A external-priority patent/GB8926045D0/en
Priority claimed from GB909019552A external-priority patent/GB9019552D0/en
Application filed by Unilever Plc, Unilever Nv filed Critical Unilever Plc
Publication of GR3017407T3 publication Critical patent/GR3017407T3/el

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12P—FERMENTATION OR ENZYME-USING PROCESSES TO SYNTHESISE A DESIRED CHEMICAL COMPOUND OR COMPOSITION OR TO SEPARATE OPTICAL ISOMERS FROM A RACEMIC MIXTURE
    • C12P21/00—Preparation of peptides or proteins
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/395—Antibodies; Immunoglobulins; Immune serum, e.g. antilymphocytic serum
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K16/00—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
    • C07K16/40—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against enzymes
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K2317/00—Immunoglobulins specific features
    • C07K2317/20—Immunoglobulins specific features characterized by taxonomic origin
    • C07K2317/24—Immunoglobulins specific features characterized by taxonomic origin containing regions, domains or residues from different species, e.g. chimeric, humanized or veneered
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K2319/00—Fusion polypeptide
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K2319/00—Fusion polypeptide
    • C07K2319/01—Fusion polypeptide containing a localisation/targetting motif
    • C07K2319/02—Fusion polypeptide containing a localisation/targetting motif containing a signal sequence

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Organic Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Immunology (AREA)
  • Zoology (AREA)
  • Wood Science & Technology (AREA)
  • Microbiology (AREA)
  • Biochemistry (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Molecular Biology (AREA)
  • Genetics & Genomics (AREA)
  • Epidemiology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Animal Behavior & Ethology (AREA)
  • Biotechnology (AREA)
  • Biophysics (AREA)
  • General Chemical & Material Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Mycology (AREA)
  • General Engineering & Computer Science (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Peptides Or Proteins (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Saccharide Compounds (AREA)
  • Hydrogenated Pyridines (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Luminescent Compositions (AREA)
  • Fireproofing Substances (AREA)
  • Solid-Sorbent Or Filter-Aiding Compositions (AREA)
  • Dental Preparations (AREA)
  • Paper (AREA)
GR950402540T 1989-11-17 1995-09-13 Specific binding agents. GR3017407T3 (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
GB898926045A GB8926045D0 (en) 1989-11-17 1989-11-17 Specific binding agents
GB909019552A GB9019552D0 (en) 1990-09-07 1990-09-07 Specific binding agents

Publications (1)

Publication Number Publication Date
GR3017407T3 true GR3017407T3 (en) 1995-12-31

Family

ID=26296218

Family Applications (1)

Application Number Title Priority Date Filing Date
GR950402540T GR3017407T3 (en) 1989-11-17 1995-09-13 Specific binding agents.

Country Status (16)

Country Link
EP (1) EP0429242B1 (el)
JP (1) JPH05501357A (el)
KR (2) KR970007782B1 (el)
AT (1) ATE123815T1 (el)
AU (1) AU652923B2 (el)
BG (1) BG60687B1 (el)
CA (1) CA2066670A1 (el)
DE (1) DE69020112T2 (el)
DK (1) DK0429242T3 (el)
ES (1) ES2075169T3 (el)
FI (1) FI922220A (el)
GR (1) GR3017407T3 (el)
HU (1) HUT64600A (el)
NO (2) NO303066B1 (el)
RO (1) RO110262B1 (el)
WO (1) WO1991007500A1 (el)

Families Citing this family (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB9019553D0 (en) * 1990-09-07 1990-10-24 Unilever Plc Specific binding agents
WO1992022653A1 (en) * 1991-06-14 1992-12-23 Genentech, Inc. Method for making humanized antibodies
WO1994004679A1 (en) * 1991-06-14 1994-03-03 Genentech, Inc. Method for making humanized antibodies
US6800738B1 (en) 1991-06-14 2004-10-05 Genentech, Inc. Method for making humanized antibodies
GB0510790D0 (en) 2005-05-26 2005-06-29 Syngenta Crop Protection Ag Anti-CD16 binding molecules
JP5297742B2 (ja) * 2008-09-26 2013-09-25 株式会社青木科学研究所 金型用粉体含有油性潤滑剤、これを用いた静電塗布方法、及び静電塗布装置
PT3383920T (pt) * 2015-11-30 2024-04-15 Univ California Entrega de carga útil específica para tumores e ativação imune utilizando um anticorpo humano que tem como alvo um antigénio altamente específico da superfície das células tumorais
CN112601546B (zh) * 2018-06-12 2024-04-16 湖南远泰生物技术有限公司 Plap-car-效应细胞
CN116745324A (zh) 2021-01-27 2023-09-12 信达生物制药(苏州)有限公司 针对cd16a的单域抗体及其用途
AU2022366987A1 (en) 2021-10-14 2024-05-16 Arsenal Biosciences, Inc. Immune cells having co-expressed shrnas and logic gate systems
CN114014933B (zh) * 2021-11-17 2023-05-02 福州迈新生物技术开发有限公司 抗plap蛋白单克隆抗体、细胞系及其制备方法和应用

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB8607679D0 (en) * 1986-03-27 1986-04-30 Winter G P Recombinant dna product

Also Published As

Publication number Publication date
BG96346A (bg) 1993-12-24
CA2066670A1 (en) 1991-05-18
HU9201619D0 (en) 1992-08-28
HUT64600A (en) 1994-01-28
KR970007782B1 (ko) 1997-05-16
NO921941D0 (no) 1992-05-15
FI922220A0 (fi) 1992-05-15
DE69020112D1 (de) 1995-07-20
WO1991007500A1 (en) 1991-05-30
EP0429242A2 (en) 1991-05-29
NO980656D0 (no) 1998-02-16
BG60687B1 (bg) 1995-12-29
JPH05501357A (ja) 1993-03-18
NO980656L (no) 1992-05-15
ES2075169T3 (es) 1995-10-01
NO921941L (no) 1992-05-15
DE69020112T2 (de) 1995-11-02
EP0429242B1 (en) 1995-06-14
NO303066B1 (no) 1998-05-25
FI922220A (fi) 1992-05-15
RO110262B1 (ro) 1995-11-30
KR920703837A (ko) 1992-12-18
DK0429242T3 (da) 1995-10-16
ATE123815T1 (de) 1995-06-15
EP0429242A3 (en) 1991-06-05
AU652923B2 (en) 1994-09-15
KR970007783B1 (ko) 1997-05-16
AU6736990A (en) 1991-06-13

Similar Documents

Publication Publication Date Title
GB9019553D0 (en) Specific binding agents
GR3017407T3 (en) Specific binding agents.
IN157982B (el)
PT99934A (pt) Processo para a producao de um anticorpo anti-htnf alfa recombinante ou humanizado
DK0687295T3 (da) Human B-lymfoblastoidcellelinje, der secernerer anti-gangliosid-antistof
EP0339163A3 (en) Monoclonal antibodies specific for hiv and hybridomas for their production
CA2348698A1 (en) Variants of humanized anti-carcinoma monoclonal antibody cc49
NO174110C (no) Monoklonalt antistoff til anvendelse in vitro for diagnose av maligne tumor- eller akutte inflammasjonssykdommer, og som er spesifikt for N-acetyl-neuraminsyre i hybridom som produserer antistoffet
DE69334036D1 (de) Hybridom und humanisierter monoklonaler anti-kc-4-antikörper, dafür kodierende dnas und rnas, kit und diagnostische verfahren
EP0166458A3 (en) Monoclonal antibody capable of specifically distinguishing human hepato-carcinoma cells
FR2697088B1 (fr) Anticorps monoclonaux pour le diagnostic différentiel de cancers épithéliaux dans des épanchements séreux, hybridomes les secrétant et kit de diagnostic.
ZA878078B (en) Murine hybridoma lym-1 and diagnostic antibody produced thereby
PT99114A (pt) Processo para a preparacao de anticorpos monoclonais dirigidos contra complexos formados por trombina e inibidores de trombina
DE3375516D1 (en) Monoclonal antibody specific for human blood group antigen k (cellano), and hybridoma cell lines producing these monoclonal antibodies
HUT48677A (en) Process for producing mouse hybridoma lym-2 and diagnostic antibody therefrom
DE3787220D1 (de) Monoklonaler Antikörper gegen menschliches Plasminogen, Verfahren zu seiner Herstellung, diesen Antikörper enthaltendes Testreagenz sowie Testsatz und diesen Antikörper produzierendes Hybridoma.
AU2002329509A1 (en) Anti-ssrp-1 monoclonal antibodies and hybridomas producing said antibodies
PH23953A (en) Murine hybridoma lym-1 and diagnostic antibody produced thereby